ZA200710600B - Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones - Google Patents

Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones

Info

Publication number
ZA200710600B
ZA200710600B ZA200710600A ZA200710600A ZA200710600B ZA 200710600 B ZA200710600 B ZA 200710600B ZA 200710600 A ZA200710600 A ZA 200710600A ZA 200710600 A ZA200710600 A ZA 200710600A ZA 200710600 B ZA200710600 B ZA 200710600B
Authority
ZA
South Africa
Prior art keywords
fumagillin
bioavailability
derivatives
increase
macrocyclic lactones
Prior art date
Application number
ZA200710600A
Other languages
English (en)
Inventor
Alvinerie Michel
Dupuy Jacques
Lespine Anne
Sutra Jean-Francois
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Publication of ZA200710600B publication Critical patent/ZA200710600B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200710600A 2005-06-08 2006-06-08 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones ZA200710600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0505829A FR2886855B1 (fr) 2005-06-08 2005-06-08 Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques

Publications (1)

Publication Number Publication Date
ZA200710600B true ZA200710600B (en) 2009-05-27

Family

ID=35064492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200710600A ZA200710600B (en) 2005-06-08 2006-06-08 Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones

Country Status (9)

Country Link
US (2) US20080200402A1 (fr)
EP (1) EP1888116A2 (fr)
AU (1) AU2006256616A1 (fr)
BR (1) BRPI0611642A2 (fr)
CA (1) CA2611201A1 (fr)
FR (1) FR2886855B1 (fr)
MX (1) MX2007015504A (fr)
WO (1) WO2006131649A2 (fr)
ZA (1) ZA200710600B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009270799B2 (en) * 2008-07-18 2016-05-19 Zafgen, Inc. Methods of treating an overweight or obese subject
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
US20120004162A1 (en) 2008-12-04 2012-01-05 Vath James E Methods of Treating an Overweight or Obese Subject
AU2010303270A1 (en) 2009-10-09 2012-05-03 Zafgen Corporation Sulphone compounds for use in the treatment of obesity
US8815309B2 (en) 2010-01-08 2014-08-26 Zafgen, Inc. Methods of treating a subject with benign prostate hyperplasia
AU2011204267B2 (en) 2010-01-08 2015-12-03 Zafgen Corporation Fumagillol type compounds and methods of making and using same
US20130266578A1 (en) 2010-04-07 2013-10-10 Thomas E. Hughes Methods of treating an overweight subject
KR20130043207A (ko) 2010-07-22 2013-04-29 자프겐 인크. 트리시클릭 화합물 및 이의 제조 및 사용 방법
NZ610569A (en) 2010-11-09 2015-06-26 Zafgen Inc Crystalline solids of a metap-2 inhibitor and methods of making and using same
BR112013013411A2 (pt) 2010-11-29 2016-09-13 Zafgen Inc tratamento de obesidade usando administração não diária de 6-0-(4-dimetilaminoetxi) cinamoil fumagilol
JP6058557B2 (ja) 2011-01-26 2017-01-11 ザフゲン，インコーポレイテッド テトラゾール化合物ならびにその作製方法および使用方法
WO2012122264A1 (fr) 2011-03-08 2012-09-13 Zafgen Corporation Dérivés d'oxaspiro[2.5]octane et analogues
US9351988B2 (en) 2011-05-02 2016-05-31 Universite De Geneve Macrocyclic lactones and use thereof
BR112013028665A2 (pt) 2011-05-06 2016-09-06 Zafgen Inc compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
BR112013028534A2 (pt) 2011-05-06 2016-09-06 Zafgen Inc compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos
BR112013028666A2 (pt) 2011-05-06 2017-08-08 Zafgen Inc compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo
EP2763671A2 (fr) 2011-10-03 2014-08-13 Zafgen, Inc. Méthodes de traitement de troubles liés à l âge
EP2804856B1 (fr) 2012-01-18 2017-03-15 Zafgen, Inc. Composés sulfones tricycliques et leurs procédés de fabrication et d'utilisation
JP6035347B2 (ja) 2012-01-18 2016-11-30 ザフゲン，インコーポレイテッド 三環式スルホンアミド化合物ならびにその作製および使用方法
KR20150016303A (ko) 2012-05-07 2015-02-11 자프겐 인크. 6-o-(4-디메틸아미노에톡시) 신나모일 푸마지롤의 옥살레이트 염의 다형체 염 및 이의 제조 및 사용 방법
CA2872876A1 (fr) 2012-05-08 2013-11-14 Zafgen, Inc. Traitement de l'obesite hypothalamique au moyen d'inhibiteurs de metap2
EP2850079B1 (fr) 2012-05-09 2018-05-02 Zafgen, Inc. Dérivés de fumigillol, procédés pour leurs préparation et leurs utilisation
CN104918615B (zh) 2012-11-05 2018-10-12 扎夫根股份有限公司 治疗肝病的方法
EP2925737B1 (fr) 2012-11-05 2017-06-14 Zafgen, Inc. Composés tricycliques à utiliser dans le traitement et/ou la lutte contre l'obésité
CA2890342A1 (fr) 2012-11-05 2014-05-08 Zafgen, Inc. Composes tricycliques et procedes de fabrication et d'utilisation associes
EP2968250B1 (fr) 2013-03-14 2019-06-19 Zafgen, Inc. Méthodes de traitement de maladie rénale et d'autres troubles
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
DK2970101T3 (en) 2013-03-14 2018-08-20 Alkermes Pharma Ireland Ltd PRO-DRUGS OF FUMARATES AND THEIR USE IN TREATING DIFFERENT DISEASES
CA2940845C (fr) 2014-02-24 2019-09-24 Alkermes Pharma Ireland Limited Sulfonamide et promedicaments de fumarates de sulfinamide et leur utilisation dans le traitement de diverses maladies
TW201636342A (zh) 2014-12-19 2016-10-16 武田藥品工業有限公司 煙黴醇衍生物
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
EP0658342B1 (fr) * 1993-09-24 1999-03-17 Takeda Chemical Industries, Ltd. Composition pharmaceutique antineoplastique contenant des dérivées de fumagillol et un complex du platine
NZ304906A (en) * 1995-03-27 1999-06-29 Sanofi Sa Use of fumagillol or a fumagillol ester and an optionally saturated alkylcarboxylic or alkyldicarboxylic acid to fight intestinal infections
CA2210600A1 (fr) * 1996-07-17 1998-01-17 Takashi Houkan Inhibiteur des metastases tumorales ou de la recurrence
CA2381829A1 (fr) * 2001-05-18 2002-11-18 Margaret Ann Smith Dordal Methode de traitement de tumeurs avec des derives du fumagillol
HUP0203718A2 (hu) * 2002-10-31 2004-08-30 Annamária Szőke Orális adagolású, állatgyógyászati hatóanyagot tartalmazó készítmény, és/vagy táplálékkiegészítő készítmény, eljárás annak előállítására és annak alkalmazása

Also Published As

Publication number Publication date
BRPI0611642A2 (pt) 2010-09-28
US20080200402A1 (en) 2008-08-21
FR2886855B1 (fr) 2009-07-17
WO2006131649A2 (fr) 2006-12-14
EP1888116A2 (fr) 2008-02-20
FR2886855A1 (fr) 2006-12-15
MX2007015504A (es) 2008-03-18
CA2611201A1 (fr) 2006-12-14
AU2006256616A1 (en) 2006-12-14
US20110144045A1 (en) 2011-06-16
WO2006131649A3 (fr) 2007-06-21

Similar Documents

Publication Publication Date Title
ZA200710600B (en) Use of fumagillin and the derivatives thereof to increase the bioavailability of the macrocyclic lactones
IL186837A0 (en) Chromane and chromene derivatives and uses thereof
ZA200709043B (en) Benzodioxane and benzodioxalane derivatives and uses thereof
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
IL186297A0 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
IL180252A (en) Compounds and Methods for Preparing @Lycondrin Analog @ b
PL1856129T3 (pl) 39-desmetoksypochodne rapamycyny
EP1930328A4 (fr) Esters polycycliques contenant un groupe cyano ayant des squelettes de lactone
ZA200707427B (en) Flavonoid compounds and uses thereof
EP1871761A4 (fr) Derives spirocycliques heterocycliques et procedes d'utilisation
HK1094451A1 (en) Ascorbic acid derivatives and skin-whitening cosmetics
HK1122797A1 (en) Derivatives of pyrido
EP1620419A4 (fr) Derives stabilises d'acide ascorbique
PT1898901T (pt) Formas de dosagem estáveis de antimaláricos de espiro- e diespiro-1,2,4-trioxolano
IL188449A0 (en) Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease
ZA200800348B (en) Derivatives of seleno-amino acids
EP1932527A4 (fr) Utilisation de dérivés du phthalide
ATE369347T1 (de) Trimere makrocyclisch substituierte halogen- benzolderivate
IL180777A (en) Chromen-2- one derivatives, pharmaceutical compositions comprising them and uses thereof
ZA200709307B (en) Spirocyclic heterocyclic derivatives and methods of their use
IL177105A0 (en) Coumarin derivative and use thereof
DE602006017662D1 (de) Ech sowie folie und daraus geformter artikel
IL188241A0 (en) Cripowellins and synthetic derivatives thereof used as medicaments
IL183705A0 (en) Macrocyclic quinazole derivatives and their use as mtki
AU2006332419A1 (en) The use of phthalide derivatives